In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis
about
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroEvaluation of ciprofloxacin 500 mg twice daily for one week in treating uncomplicated gonococcal chlamydial, and non-specific urethritis in men.Ciprofloxacin treatment of chlamydial infections of urogenital tracts of womenBiotypes, serotypes, and susceptibility to antibiotics of 60 Haemophilus influenzae strains from genitourinary tractsPersistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitroIn vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains.In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatisSusceptibility testing of Chlamydia trachomatis: from eggs to monoclonal antibodies.Activities of new quinoline derivatives against genital pathogens.In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens.Failure of norfloxacin to eradicate Chlamydia trachomatis in nongonococcal urethritis.Comparative study of cefoperazone and spectinomycin for treatment of uncomplicated gonorrhea in men.Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescenceComparative trial of single-dose ciprofloxacin and ampicillin plus probenecid for treatment of gonococcal urethritis in men.Norfloxacin in the therapy of uncomplicated gonorrhea.In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.Female genital Chlamydia trachomatis infection: where are we heading?Quinolone antibacterial agents for the treatment of genitourinary tract infections.In-vitro activity of ofloxacin against Chlamydia trachomatis.In vitro activities of temafloxacin (A-62254) and four other antibiotics against Chlamydia trachomatis.In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis.In vitro activity of antibiotics against Ureaplasma urealyticum and Chlamydia trachomatis strains from patients with nongonococcal urethritis.Activity of the newer quinolones against Chlamydia trachomatis.Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.Determination of norfloxacin and ciprofloxacin concentrations in serum and urine by high-pressure liquid chromatography.The place of quinolones in antibacterial therapy in hospitals.
P2860
Q24670241-532C1D33-F650-48C4-92D2-40FEC7A2D015Q33583148-BF944E4A-C082-43A9-8781-AB06674A599FQ33931483-245F6CA0-CC86-4233-9958-8061FBC5CBD6Q33931694-71E8E959-8ACD-40F8-8030-7201A11E1F4CQ33980950-B5962BF4-59C3-4A7F-A844-7166226D0BE7Q34681907-E33CD009-4856-4978-8493-6532C5DC1022Q35535767-480B1A01-B631-4C9F-A7B8-E733E1C21444Q35563517-FED0F19F-3432-458B-ACD3-79FC19EEB5B4Q35568919-A257FE6D-E717-4280-BDF3-83AB6763E7B3Q35575253-C15AF7CA-62DE-4410-AF6B-E50E2EC2BBF5Q35575297-6EB86017-2757-4AB3-8A76-4B6B647A6253Q35575504-94E6845B-F8C7-47D1-9CED-0AC9C5EC9852Q35639438-8D12B9B2-2E63-4F16-8889-DC320E378B7BQ35651395-C605BEF7-4EE3-40D8-9FA1-2969BF7F7A33Q35653365-E24680DD-221D-41EF-AE5B-2344E0893D19Q35653982-F5FAADE4-2FEC-4D4F-9C52-B445F5133671Q37849297-74F820A3-2F49-48AF-9B71-0BF15F766F2FQ37897445-42264148-3DC8-4737-8678-2D0A94C0F077Q37897912-21F444E9-EFF6-43DB-BA01-204680644B53Q37899020-488B1DB3-80E5-4081-98F5-8404BE672EB9Q37899417-19B2794D-C625-475E-9BEA-2AE25284A2A8Q37900001-2F3B59C3-4054-4771-BA96-7FD99EF70BD6Q37905259-5B3B4585-B470-4115-B4E4-AD265A115CF0Q39730719-DD7BB719-B960-4605-9366-DA2637727C83Q39851432-6886F2C5-6C0E-43EB-ACD1-02D24F0F4F5FQ54432495-8E4E8864-2065-4255-8C86-5DC558D266C3
P2860
In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
In vitro activities of ciprofl ...... against Chlamydia trachomatis
@en
In vitro activities of ciprofl ...... against Chlamydia trachomatis.
@nl
type
label
In vitro activities of ciprofl ...... against Chlamydia trachomatis
@en
In vitro activities of ciprofl ...... against Chlamydia trachomatis.
@nl
prefLabel
In vitro activities of ciprofl ...... against Chlamydia trachomatis
@en
In vitro activities of ciprofl ...... against Chlamydia trachomatis.
@nl
P2860
P356
P1476
In vitro activities of ciprofl ...... against Chlamydia trachomatis
@en
P2093
Heessen FW
Muytjens HL
P2860
P304
P356
10.1128/AAC.25.1.123
P407
P577
1984-01-01T00:00:00Z